Gabather AB (publ) (GABA.ST)
Gabather AB (publ) operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Södertälje, SN, SE. The stock last traded at $0.03, up 7.94% on the session, giving a market capitalisation of $6.4M. Its beta of -0.75 implies it has historically moved less than the broad market.
Gabather AB (publ) is dedicated to creating innovative pharmaceutical solutions for a range of central nervous system disorders. The company's focus includes developing medications for conditions such as psychotic illnesses, mood and anxiety disorders, pain relief, and cognitive function enhancement, notably those related to Alzheimer's disease. Founded in 2014, its operations are headquartered in Södertälje, Sweden.
Gabather AB (publ) is most often compared with the following Healthcare names: